Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why C.R. Bard Is Poised to Outperform

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device company C.R. Bard (NYSE: BCR  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at C.R. Bard and see what CAPS investors are saying about the stock right now.

C.R. Bard facts



Headquarters (founded)

Murray Hill, N.J. (1907)

Market Cap

$8.1 billion


Healthcare equipment

Trailing-12-Month Revenue

$3.0 billion


Chairman/CEO Timothy Ring

President/COO John Weiland

Return on Equity (average, past 3 years)



$896.3 million / $1.4 billion

Dividend Yield



Boston Scientific

Johnson & Johnson 

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 279 members who have rated C.R. Bard believe the stock will outperform the S&P 500 going forward.

Earlier this week, one of those Fools, All-Star JohnCLeven, succinctly summed up the C.R. Bard bull case for our community:

[C.R. Bard] has been on my radar for a while. [C.R. Bard] exhibits many of the characteristics that I find appealing in a business including: high returns on capital and equity, consistent growth in earnings and free cash flows, share buybacks, and a solid balance sheet.

[C.R. Bard] has a solid position within the medical device industry, and I believe that probability is very high that [C.R. Bard] will continue to create significant value over the next 5-10 years, and probably much longer. At today's 6.8% free cash flow yield, this high-quality business should outperform in the long run.

If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong five-star rating, C.R. Bard may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2386687, ~/Articles/ArticleHandler.aspx, 9/26/2016 12:12:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,112.09 -149.36 -0.82%
S&P 500 2,150.29 -14.40 -0.67%
NASD 5,263.42 -42.33 -0.80%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 11:57 AM
BCR $228.26 Down -1.65 -0.72%
C.R. Bard CAPS Rating: ****